Skip navigation

Global Disclosure Requirements • Patients as Partners • Data Sharing Policies • Publications Strategy

June 10-11, 2020
  • London, United Kingdom

Join us at CBI’s 9th Annual Publication and Clinical Trial Transparency conference to participate in a knowledge exchange and gain insight on EMA’s strategic priorities, benchmark industry trends in clinical trial transparency and establish timelines and best practices for publication planning in accordance with ICMJE and GPP3 guidelines.

It is never more critical than now to gather with your colleagues from clinical trial transparency, data management, publications and medical writing to exchange proven best practices and better understand how your peers are preparing to comply with changing regulations.

Key Insights and Takeaways:

  • Deconstruct results posting and data sharing challenges
  • Explore innovative publication and medical
    communication strategies
  • Collaborate with patients and partners for positive
    clinical data disclosure practices
  • Share updates to Policy 0070 implementation standards
    across industry
  • Identify the synergies between publishing lay summaries
    and publications
  • Evaluate the intended purpose and reality of
    publishers’ guidelines
  • Build a knowledge center for understanding global transparency requirements and communicating them to your teams
  • Analyze how the EU GDPR has effected transparency policies across European pharmaceutical companies
  • Connect publications timelines with disclosure priorities for
    a more effective results sharing process

Previous Attendee Acclaim:

This conference was a real eye-opener into the current context and challenges faced by those involved with transparency & disclosure of clinical trials and publications. After two days of collaborative and multi-disciplinary discussions, I am truly excited to see how patients and the public are engaged and involved in forming and implementing valuable solutions to these problems that go beyond just meeting legal requirements.

Informative and necessary congress.

Trial Transparency Manager, Sanofi

Well-organized conference allowing a lot of
interactions in between participants and between participants, speakers, and sponsors.

Senior Medical Writer, Swedish Orphan Biovitrum

A good forum to share progress in the
different but interconnected fields!

Anonymous

9th Annual Publication and Clinical Trial Transparency

Global Disclosure Requirements • Patients as Partners • Data Sharing Policies • Publications Strategy

Join us at CBI’s 9th Annual Publication and Clinical Trial Transparency conference to participate in a knowledge exchange and gain insight on EMA’s strategic priorities, benchmark industry trends in clinical trial transparency and establish timelines and best practices for publication planning in accordance with ICMJE and GPP3 guidelines.

It is never more critical than now to gather with your colleagues from clinical trial transparency, data management, publications and medical writing to exchange proven best practices and better understand how your peers are preparing to comply with changing regulations.

Key Insights and Takeaways:

  • Deconstruct results posting and data sharing challenges
  • Explore innovative publication and medical
    communication strategies
  • Collaborate with patients and partners for positive
    clinical data disclosure practices
  • Share updates to Policy 0070 implementation standards
    across industry
  • Identify the synergies between publishing lay summaries
    and publications
  • Evaluate the intended purpose and reality of
    publishers’ guidelines
  • Build a knowledge center for understanding global transparency requirements and communicating them to your teams
  • Analyze how the EU GDPR has effected transparency policies across European pharmaceutical companies
  • Connect publications timelines with disclosure priorities for
    a more effective results sharing process

Previous Attendee Acclaim:

This conference was a real eye-opener into the current context and challenges faced by those involved with transparency & disclosure of clinical trials and publications. After two days of collaborative and multi-disciplinary discussions, I am truly excited to see how patients and the public are engaged and involved in forming and implementing valuable solutions to these problems that go beyond just meeting legal requirements.

Informative and necessary congress.

Trial Transparency Manager, Sanofi

Well-organized conference allowing a lot of
interactions in between participants and between participants, speakers, and sponsors.

Senior Medical Writer, Swedish Orphan Biovitrum

A good forum to share progress in the
different but interconnected fields!

Anonymous